Breaking News, Promotions & Moves

Cobra Biologics Appoints Innovation Director

Sleep will work drive technical innovation to streamline process workflows and advance ATMP service offering

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Darrell Sleep has been appointed director of Innovation at Cobra Biologics. The appointment is part of on-going strategic expansion activities underway at Cobra’s Keele, UK site, to increase capacity and capability for clinical and commercial in-market supply of viral vector and DNA products to Advanced Therapy Medicinal Product (ATMP) developers.    Dr. Sleep will lead the site’s innovation team of in-house R&D and process development expertise. The combined innovation team will deliv...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters